Mindark redovisade minskad nettoomsättning och EBIT i det första kvartalet.
Redeye provides an in-depth review of AcouSort’s Q1 report and events during and after the quarter.
Xoma är en svensk teknikleverantör som utvecklar landbaserade system för algodling och rening av pro...
Redeye returns with an updated view of Saniona following the Q1 report and recent events in the comp...
Redeye updates its view on Verve Group following its Q1 2025 report, which came in softer than expec...
Solwers posted a weak Q1, with revenue largely in line with our expectation but profitability clearl...
Redeye provides a research update following MindArk’s softer-than-expected Q1 report.
Redeye comments on FluoGuide’s Q1 2025 report while the company’s phase II HNC interim readout draws...
Redeye comments on MindArk’s Q1 results, which were weaker than expected.
Redeye comments on Verve Group’s Q1 2025 results, which were in line with expectations in terms of t...
Solwers reported its results for Q1 (condensed business review) with sales of EUR 20.
At its Capital Markets Day on 27 May, Sivers Semiconductors delivered a message that was clear, focu...
Doro sales up 13% y-o-y in Q1, subscriptions launching in H2 '25e-'28e EBIT CAGR of 32%.
Chordate Medical redovisade ökad nettoomsättning och minskad rörelseförlust i det första kvartalet.
Redeye comments on Klaria’s announcement earlier today regarding a SEK9.
Systemair väntas visa oförändrad eller något lägre försäljning i Q4, pressad av starkare krona.
Redeye returns following Kancera's Q1 report. The investment case is currently centred around the le...
Hansa Biopharma plans to restructure the organisation to optimise resource allocation and improve op...
Redeye comments on Lipigon’s first quarter report 2025.
Organic sales growth of 13% y-o-y in Q1 Profitability improvement in Security Solutions.
